Loading
Scott Kahn

Scott Kahn

Chairman, ICAN Biomarkers Council; Founder, Alykomed Global Solutions LLC
-Currently founder of Alykomed Global Solutions LLC, strategizes with C-level corporate teams on M&A, raising capital -Founded Intercept Pharmaceuticals non-invasive biomarker group- Phase II/III clinical programs, external collaborations. -CSO of Oncostem Biotherapeutics- preclinical strategy -Founding Biomarker Council Chairman, ICAN- leads world class team of ~40 leading industry/academic scientists -PI of academic research groups at Columbia University- collaborated with academic and clinical thought leaders, and industry groups (large-cap companies, innovators) - Matrix environment- established/led cross-functional, multidimensional, internal-external, project focused teams
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS